Isis nets $195m from note sale to pay down debt
This article was originally published in Scrip
Executive Summary
Isis Pharmaceuticals announced the private sale of convertible senior notes due in 2019 with an aggregate principal amount totalling $201.25 million on 9 August, which will yield net proceeds of $194.8 million to redeem outstanding convertible subordinated notes due in 2027 and cover other corporate expenses.